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Abstract
Background: To evaluate the influence of microbial invasion of the amniotic cavity (MIAC) and histological chorioamnionitis
(HCA) on the magnitude of intra-amniotic inflammatory response in preterm prelabor rupture of membranes (PPROM).
Methodology/Principal Finding: A prospective cohort study was performed in 107 women with PPROM between 23.0 and
36.6 weeks of gestational age. Twenty-six proteins were assayed by multiple immunoassay in amniotic fluid. The policy for
PPROM in Czech Republic is active, and 90% of the women were delivered within 96 hours of membrane rupture.
Histopathological placental findings were evaluated based on the Salafia classification. Data were analyzed in four
subgroups of population according to the presence of MIAC and/or HCA. Results were stratified by gestational age at
PPROM (, or $34.0 weeks). The rates of MIAC and HCA were 44% and 57%, respectively. Regardless of gestational age at
PPROM, intra-amniotic inflammatory response was higher when MIAC and HCA were both present. There were no
differences in the intra-amniotic inflammatory response between women with MIAC or HCA alone and women without
infection.
Conclusion: A higher intra-amniotic inflammatory response was identified when both HCA and MIAC were detected.
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Introduction
Microbial invasion of the amniotic cavity (MIAC) has been
extensively related to neonatal morbidity and mortality in
pregnancies with preterm prelabor rupture of membranes
(PPROM) [1–5]. However, the presence of intra-amniotic
inflammatory status seems to be as important for the occurrence
of preterm delivery and neonatal complications as the identifica-
tion of microorganisms in the amniotic fluid [6–11]. Higher intra-
amniotic inflammatory response has been reported in the presence
of MIAC [6–9] and in the presence of histological chorioamni-
onitis (HCA) [10,11], suggesting that not only the amniotic cavity
but also the placenta may play a role in the inflammatory
response.
Few studies have explored the intensity of the intra-amniotic
inflammatory response in different compartments (e.g. amniotic
fluid and placenta or different parts of the placenta and the fetus).
In a mixed group of women with HCA who delivered
(spontaneously and electively) before 36 weeks, Parker et al [12]
observed a more intense intra-amniotic inflammatory response
and a worse neonatal outcome when the inflammatory process
involved the amnion layer in addition to the chorion layer,
suggesting that the deeper the placental involvement the more
severe the inflammatory response. Davies et al [13] evaluated the
natural course of acute inflammation in the placenta, uterus and
fetal lung in a rabbit model infected by Escherichia coli and reported
earlier response to inflammation in the uterine tissue and the
placenta than in the fetal lung.
The policy of active management of women with PPROM in
the Czech Republic [14] provides a unique possibility for
evaluation of the amniotic fluid, placenta and umbilical cord with
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little time discrepancies between sampling of the different
compartments.
Since intra-amniotic inflammation seems to be a risk factor for
morbidity in PPROM at least as important as MIAC, the aim of
this study was to evaluate the magnitude of intra-amniotic
inflammatory response according to the presence of MIAC and
HCA.
Methods
Study population and procedures
We studied pregnant women between 23.0 to 36.6 weeks of
gestation with a diagnosis of PPROM who were admitted to the
Department of Obstetrics and Gynecology, University Hospital
Hradec Kralove, Czech Republic, between July 2008 and October
2010. Gestational age was established according to the first-
trimester ultrasound scan. Multiple pregnancies, structural/chro-
mosomal anomalies and patients with clinical signs of chorioam-
nionitis or vaginal bleeding at admission were not considered
eligible for this study.
PPROM was defined as leakage of amniotic fluid preceding the
presence of cervical changes and the onset of uterine contractions.
PPROM was diagnosed by a sterile speculum examination to
identify pooling of amniotic fluid in the vagina in association with
a positive test for the presence of insulin-like growth factor–
binding protein (ACTIM PROM test; MedixBiochemica, Kau-
niainen, Finland) in the vaginal fluid.
A complete course of antenatal steroids, betamethasone 12-mg
intramuscular injection with two doses given 24 h apart, was
administered when PPROM occurred between 24.0 to
33.6 weeks. Tocolysis was considered for 48 h in the absence of
clinical chorioamnionitis, abruptio placentae and fetal compro-
mise. Prophylactic parenteral broad-spectrum antibiotics were
given at admission. No treatment except antibiotics was initiated
to delay delivery after 34 weeks. Management of PPROM women
in the Czech Republic [14] differs substantially from most clinical
guidelines. Management of PPROM is active except for PPROM
pregnancies at ,28 weeks of gestation, which are handled with
expectant care. Timing for induction of labor or elective caesarean
section depends on gestational age at membranes rupture (within
24 hours (h) in those with gestational age above 34.0 weeks, within
48 hours in those between 32.0 and 33.6 weeks of gestation, and
within 72 hours after membrane rupture between 28.0 and
31.6 weeks). Fetal and maternal status were closely monitored
until delivery. Maternal serum C-reactive protein (CRP) and white
blood cell (WBC) concentrations were assayed upon admission and
every subsequent day until delivery.
Ultrasound-guided transabdominal amniocentesis was per-
formed at admission before the administration of corticosteroids,
antibiotics or tocolytics. Cultures for aerobic and anaerobic
bacteria, as well as polymerase chain reaction analysis (PCR) for
genital mycoplasmas and Chlamydia trachomatis, were assayed
immediately after collection. The results were available for clinical
management. Protease inhibitors (CompleteTM Mini, EDTA-free
Protease Inhibitor Cocktail; Roche Diagnostics, Basel, Switzer-
land) were added to the remaining amniotic fluid (40 mL per 1 mL
of amniotic fluid). The amniotic fluid was centrifuged for
15 minutes at 2000x g to remove cells and debris, filtered (0.22-
mm Syringe-driven filter; TPP, Trasadingen, Switzerland), divided
into aliquots and stored at 270uC until analysis.
Twenty six proteins were tested in amniotic fluid using a
multiple sandwich immunoassay based on flowmetric Luminex
xMAP technology. Methodology used is described in extenso later in
methods section.
MIAC was defined as a positive PCR for genital mycoplasmas
and/or Chlamydia trachomatis, and/or a positive amniotic fluid
culture. The presence of coagulase-negative Staphylococcus epidermi-
dis in amniotic fluid was considered as a skin contaminant, except
in women with high levels of amniotic fluid Interleukin (IL)-6 and
IL-8. The amounts of genital mycoplasma DNA in amniotic fluid
samples were also evaluated using real-time polymerase chain
reaction. Specific technique used is also described later in methods
section.
After delivery, the placenta was fixed in buffered formalin; tissue
blocks from the placenta, umbilical cord and placental membranes
were routinely embedded in paraffin and sections were stained
with hematoxylin and eosin for a standard histological examina-
tion. Histopathological examinations were performed by a single
pathologist who was blinded to the clinical status of the patients.
The degree of polymorphonuclear leukocyte infiltration was
evaluated separately according to criteria proposed by Salafia
[15] in the free membranes (amnion and chorion-decidua), the
chorionic plate and the umbilical cord. The diagnosis of HCA was
determined based on grades 3–4 in the chorion-decidua, grades 3–
4 in the chorionic plate, grades 1–4 in the amnion and/or grades
1–4 in the umbilical cord [15].
To evaluate the magnitude of intra-amniotic inflammatory
response the data were analyzed using different proteins in
amniotic fluid according to the presence of MIAC with HCA, the
presence of HCA alone, the presence of MIAC alone, and a group
with neither MIAC nor HCA (non-infection detected group).
Amniotic fluid analyses: flowmetric Luminex xMAP
technology
Amniotic fluid Interleukin (IL)-1b, IL-6, IL-8, IL-10, IL-12, IL-
17, IL-18, soluble IL-6 receptor (sIL-6r), adiponectin, brain-
derived neurotropic factor (BDNF), C-reactive protein (CRP),
granulocyte macrophage colony stimulating factor (GM-CSF),
insulin-like growth factor-binding protein (IGFBP)-1, IGFBP-3,
interferon-(IFN)c, leptin, monocyte chemotactic protein-1 (MCP-
1), migration inhibiting factor (MIF), macrophage inflammatory
protein-1 (MIP-1), matrix metalloproteinasis-9 (MMP-9), neutro-
pin-3 (NT3), regulated on activation normal T-expressed and
secreted (RANTES), tumor necrosis factor (TNF)-a, TNF-b,
soluble TNF receptor-1 (sTNF-R1) and triggering receptor
expressed on myeloid cells-1 (TREM-1) were analyzed at the
Statens Serum Institute (Department of Clinical Biochemistry and
Immunology, Copenhagen, Denmark) using a multiple sandwich
immunoassay based on flowmetric Luminex xMAP technology in
accordance with the workflow previously published [16–20]. The
undiluted samples of amniotic fluid were measured in duplicate.
Calibration curves were prepared in assay buffer (phosphate
buffered saline containing 5 mL/L Tween 20 and 10 g/L bovine
serum albumin). The means of intra-assay and inter-assay
coefficients of variation were 6% and 12%, respectively. The
defined working range described by Skogstrand et al [19,20] was
used, due to the impossibility of obtaining cytokine-free amniotic
fluid. This approach was considered to be a more accurate method
of defining sensitivity than the commonly used signal-to-noise ratio
(limit of detection). The detection level was defined as half of the
lowest level in the working range in amniotic fluid (IL-1b 5 pg/
mL, IL-6 19.5 pg/mL, IL-8 2.5 pg/mL, IL-10 10 pg/mL, IL-12
4 pg/mL, IL-17 4 pg/mL, IL-18 10 pg/mL, sIL-6r 19.5 pg/mL,
Adiponectin 488.5 pg/mL, BDNF 10 pg/mL, CRP 200 pg/mL,
GM-CSF 4 pg/mL, IGFBP-1 97.5 pg/mL, IGFBP-397.5 pg/mL,
IFN-c 4 pg/mL, leptin 97.5 pg/mL, MCP-1 2.5 pg/mL,
MIF49 pg/mL, MIP-1 39 pg/mL, MMP-9 244 pg/mL, neutro-
pin-3 (NT3) 39 pg/mL, RANTES 2.5 pg/mL, TNF-a 4 pg/mL,
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TNF-b 4 pg/mL, sTNF-R1 156.5 pg/mL, TREM-1 97.5 pg/
mL). These analyses were performed by an investigator who was
blinded to the clinical status of the women.
Detection of genital mycoplasmas: The threshold cycle
value of real-time PCR for genital mycoplasmas
The bacterial load of the genital mycoplasmas was assessed
using the threshold cycle value (Ct value). DNA was isolated from
the amniotic fluid with the QIAamp DNA Mini Kit (QIAGEN,
Hilden, Germany) following the manufacturer’s instruction. Real-
time PCR was performed on a Rotor-Gene 6000 (QIAGEN,
Hilden, Germany) with the commercial kit AmpliSensH Ureaplas-
ma/M. hominis-FRT (Federal State Institution of Science, Central
Research Institute of Epidemiology, Moscow, Russia) to detect
DNA of Ureaplasma parvum, Ureaplasma urealyticum and Mycoplasma
hominis in a common PCR tube. Controls included internal control
and PCR for beta-actin, a housekeeping gene, to examine the
presence of inhibitors of the PCR reaction.
The Ct value is defined as the intersection between an
amplification curve and a threshold line. This method measures
the concentration of target DNA in the PCR reaction. The
amount of target amplification increases at a rate of one log10
every 3.32 cycles. Thus, the higher the bacterial load of genital
mycoplasmas in the amniotic fluid the lower the Ct values.
Ethics
Written informed consent was obtained from all subjects. The
Institutional Review Board approved the collection and use of
these samples and information for research purposes (Ethics
committee of University Hospital Hradec Kralove, Sokolska 581,
500 05, Hradec Kralove. March 19, 2008; No. 200804 SO1P).
Statistical methods
Statistical analyses were performed using SPSS 19.0 for
Windows XP OS (SPSS Inc., USA). Demographic and clinical
characteristics were compared using the nonparametric Jonc-
kheere-Terpstra test and Mann-Whitney U test and results are
presented as medians (range). Categorical variables were com-
pared using linear by linear association Chi-square and are
presented as numbers (%). Spearman partial correlation was used
to adjust data for gestational age at amniocentesis sampling.
Differences were considered statistically significant at a confidence
level of p,0.05 with two-sided alternative hypotheses.
Results
Demographic data
From July 2008 to October 2010, 174 women with a diagnosis
of PPROM between 23.0 and 36.6 weeks of gestation were
admitted to hospital. A total of 145 women met the inclusion
criteria. However, amniotic fluid samples could not be retrieved
from 30 women and the placenta was not sent for histopatholog-
ical assessment in 8 women. Therefore, 107 were included in the
final analysis. Gestational age at PPROM was less than 28.0 weeks
in 18 (17%) women; between 28.0 and 31.6 weeks in 20 (19%)
women; between 32.0 and 33.6 weeks in 25 (23%) women and
beyond 34.0 weeks in 44 (41%) women. Median gestational ages
at sampling and at delivery of the entire study population were
33.1 (range: 23.6–36.5) weeks and 33.2 (range: 24.0–36.5) weeks,
respectively. Latency between membranes rupture and delivery
was ,96 h in 90% (96/107), ,72 h in 78.5% (84/107) and
,48 h in 63% (67/107) of all women. Despite active management
in PPROM women, spontaneous delivery was observed in more
than 70% of women $28.0 weeks. There were no differences in
latency from PPROM to delivery among the different subgroups
of population ,28.0 weeks.
Maternal and neonatal characteristics of the entire study group
are summarized in Table 1. The overall rate of MIAC was 44%
(47/107) and HCA was found in 57% (61/107) of women.
Considering presence or absence of MIAC and/or HCA, 31
women had MIAC and HCA, 30 women had only HCA, 16
women had only MIAC and in 30 women no infection was
detected. Gestational age at PPROM was significantly earlier in
the subgroup of women with MIAC and HCA. Since latency from
PPROM to delivery, gestational age at delivery and birth weight
may be influenced by the active management of PPROM
pregnancies beyond 28 weeks of gestation in Czech Republic,
data was adjusted by gestational age at amniocentesis sampling.
Gestational age at delivery, latency from PPROM to delivery and
birth weight remained significant lower in the subgroup with
MIAC and HCA after adjustment.
Microbial invasion of amniotic cavity
The most common microorganism isolated from amniotic fluid
was Ureaplasma urealyticum (n = 26). Other microorganisms isolated
were: Mycoplasma hominis (n = 2), Chlamydia trachomatis (n = 3),
Streptococcus agalactiae (n = 6), Streptococcus a haemolyticus (n = 2),
Streptococcus pneumoniae (n = 1), coagulase-negative Staphylococcus
epidermidis (n = 3), Staphylococcus auricularis (n = 1), Staphylococcus
hominis (n = 1), Enterococcus spp (n = 1), Enterococcus faecalis (n = 1),
Haemophylus influenzae (n = 1), Fusobacterium (n = 1), Lactobacillus spp
(n = 3), Bacillus spp (n = 2), Escherichia coli (n = 1) and Candida albicans
(n = 1). In eight cases, a polymicrobial infection in the amniotic
fluid was detected. All isolations of coagulase-negative Staphylococ-
cus epidermidis bacteria were considered as a positive amniotic fluid
culture due their high expression of amniotic fluid IL-6 and IL-8.
In women with MIAC alone, the microorganisms isolated in
amniotic fluid were: Ureaplasma urealyticum (n = 8) Mycoplasma
hominis (n = 1), Streptococcus agalactiae (n = 2), Staphylococcus
hominis (n = 1), Chlamydia trachomatis (n = 2), Candida albicans
(n = 1), Staphylococcus auricularis (n = 1), Streptococcus pneumo-
niae (n = 1), Streptococcus a haemolyticus (n = 1, Bacillus spp
(n = 1) and Lactobacillus spp (n = 1). Polymicrobial infection was
present in five women.
Intra-amniotic inflammatory response
Eight proteins (IL-1b, IL-12, IL-17, IL-18, IFN-c, RANTES,
TNF-a and TNF-b) had undetectable amniotic fluid levels in more
than 50% of the samples and were excluded from further analyses.
Therefore, eighteen proteins were analyzed to evaluate differences
in the intra-amniotic inflammatory response.
A comparison of levels of amniotic fluid cytokines and
neuropeptides in all subgroups is shown in Table 2. Of the 18
biomarkers evaluated, 14 presented significantly higher concen-
trations (measured by median (range)) in the subgroups with
MIAC and HCA than in the others. On adjustment for gestational
age at amniocentesis sampling, only the intra-amniotic inflamma-
tory response mediated by IL-6, IL-10, BDNF, MCP-1, MIP-1
and MMP-9 remained significantly higher in the presence of both
MIAC and HCA.
Since current clinical management of pregnancies complicated
with PPROM in most of countries is active beyond 34.0 weeks,
inflammatory response was evaluated in women with PPROM
,34.0 weeks and $34.0 weeks (Table 3 and 4).
In PPROM ,34.0 weeks, high intra-amniotic inflammatory
response, mediated by IL-6, IL-8, IL-10, BDNF, GMC-SF, MCP-
1, MIP-1, MMP-9 and TREM-1, was observed when both MIAC
and HCA were present. In women with PPROM $34 weeks,
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fewer inflammatory biomarkers (IL-6, IL-8 and MCP-1) were
involved compared to earlier gestational age. Finally, there were
no differences in any of the amniotic fluid cytokines evaluated
between women with MIAC or HCA alone and women without
detected infection (Table 3, 4).
Microorganism quantification in women with microbial
invasion of the amniotic cavity
To further explore the relationship between women with MIAC
and HCA and MIAC alone we used a quantitative bacterial
approach. In women with a positive PCR for genital mycoplasma
(19 women with MIAC and HCA and 9 women with MIAC
alone), the amount of genital mycoplasma DNA was evaluated
using real-time PCR. The presence of MIAC and HCA was
associated with lower threshold cycle values (median 25.7, range,
13.1–31.6) compared to the group of MIAC alone (median 30.06,
range, 26–35 p = 0.010). Therefore, the amount of genital
mycoplasma DNA was significantly higher in women with MIAC
and HCA than in those with MIAC alone.
Finally, no significant differences were observed in the
inflammatory response between genital mycoplasma and other
microorganisms isolated in women with MIAC alone (Table 5).
Discussion
High intra-amniotic inflammatory response, mediated by IL-6,
IL-10, BDNF, MCP-1, MIP-1 and MMP-9, was only identified in
PPROM pregnancies with both MIAC and HCA. Therefore, the
presence of not only MIAC but also HCA seems to be necessary to
achieve high levels of inflammatory proteins in amniotic fluid.
The mechanism responsible for activation of the inflammatory
pathway has been intensively studied. Intensity of intra-amniotic
inflammatory response increases gradually when innate immunity
defense is activated by the presence of bacteria in either the
amniotic fluid or the fetal membranes. However, it has been
suggested that intra-amniotic inflammation is elicited not only by
the activation of pattern recognition receptors recognizing specific
motifs on the surface of bacteria called pathogen-associated
molecular pattern (PAMS) but also by endogenous molecules that
signal tissue and cellular damage called ‘‘alarmins’’ [21–23].
Activated immunocompetent cells produce a broad spectrum of
inflammatory mediators and chemokines responsible for attraction
and migration of neutrophils, macrophages, and other immune
cells to the placenta and fetal membranes.
Differences in intra-amniotic inflammatory response have
previously been reported along the placenta [12] suggesting that
the infiltration of neutrophils, which are the first line of defense,
progressively advances from the chorio-decidua space through the
amnion in response to infection. Moreover, the finding of fetal
neutrophils into umbilical cord (funisitis) and in the chorionic plate
vessels has been considered the last stage of inflammatory response
associated with higher intra-amniotic inflammation and therefore
a worse neonatal outcome [12,24,25]. Intra-amniotic inflamma-
tion has been extensively proposed as a marker of MIAC in









N = 30 p p*
Maternal age 29 (18–40) 32 (25–44) 31.5 (24–44) 31 (19–40) 0.903 0.864
Nulliparity 12 (39) 18 (60) 9 (56) 20 (67) 0.190 0.055




30.5 (23.6–35.4) 33.3 (24–36.1) 34.1 (31.6–36.3) 34.2 (24.0–36.5) ,0.001 -
Latency from PPROM to
amniocentesis (hours)
5 (2–16) 6 (1–22) 4 (1–23) 6.5 (1–16) 0.681 0.660
Latency from PPROM to
delivery (hours)
34 (8–244) 39.5 (6–217) 16 (5–77) 19 (7–119) 0.019 0.016
Latency from PPROM to
delivery in PPROM ,28
weeks (hours)
64.5 (31–244) 118 (11–167) - 63 (7–119) 0.880 0.419
CRP (mg/L) 9 (0–82) 9 (1–72) 5 (0–13) 5 (0–71.3) 0.014 0.016
WBC count at admission
(x109/L)
13 (4–26.8) 12 (6.6–20) 13.05 (7–19) 11 (7–24) 0.207 0.219
Gestational age at delivery
(weeks)
31 (24.1–35.5) 33.5 (24.4–36.2) 34.1 (32.2–36.4) 34.2 (24.0–36.5) ,0.001 ,0.001
Spontaneous delivery in
PPROM $28.0 weeks
16/23 (69) 17/24 (71) 11/16 (69) 22/28 (78) 0.858 0.073
Birth weight (g) 1560 (470–2580) 2260 (495–3210) 2225 (1820–2910) 2270 (750–3460) ,0.001 ,0.001
5- min Apgar score ,7 2 (6) 4 (13) 0 1 (3) 0.264 0.364
Neonatal composite
morbidity
13 (42) 10 (33) 5 (31) 7 (23) 0.556 0.127
MIAC: Microbial invasion of amniotic cavity. HCA: Histological chorioamnionitis. PPROM: Preterm prelabor rupture of membranes. CRP: C-reactive protein. WBC: White
blood cells. Continuous variables were compared using a nonparametric Jonckheere-Terpstra test and presented as medians (range). Categorical variables were
compared using linear-by-linear association Chi-square test and presented as numbers (%). Spearman partial correlation was performed to adjust by gestational at
amniocentesis sampling (p*).
doi:10.1371/journal.pone.0043677.t001
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preterm labor with or without rupture of membranes [6–9]. The
chance in our study to examine the placental and umbilical cord
compartment within a short time period of amniotic fluid sampling
provides a unique opportunity to obtain a more complete
assessment and a better knowledge of the inflammatory response
in PPROM than previously reported. Accordingly, our data
suggest firstly that the intra-amniotic inflammatory response,
mediated by selected biomarkers, is identified only when both
MIAC and HCA are present since MIAC or HCA alone are not
associated with a higher inflammatory response when compared
with a non-infection detected group. Secondly, most of the
biomarkers involved in this inflammatory response are chemokines
participating in the recruitment of cells from the second line of
defense (MIP-1a for macrophages and MCP-1 for monocytes) and
cytokines with anti-inflammatory (IL-10) or versatile (IL-6) effects.
Surprisingly, no differences were found in IL-8, a strong attractant
of neutrophils considered the first line of defense cells against
microbial invasion. Finally, the number of biomarkers involved in
this inflammatory response was higher when PPROM occurred
before 34 weeks of gestation in line with previous data suggesting
more intense inflammatory response at earlier gestational ages
[1,6,9,26,27].
Altogether, our data suggest that intra-amniotic inflammatory
response reflects a late stage of inflammation, where both placenta
and amniotic cavity are involved. Whether MIAC or HCA alone
subgroups represent a non-pathological colonization or an early
stage of the infection that could be targeted by appropriate
treatment, remains unanswered in this study. However, from a
clinical point of view, MIAC or HCA alone do not seem to be able
per se to activate the inflammatory pathway if the other counterpart
is not affected. This finding is particularly relevant in the current
clinical management of PPROM, where clinical decisions are
mainly based on the diagnosis of MIAC and expectant manage-
ment in very early pregnancies would be desirable.
To confirm our findings related to the low inflammatory
response observed in women with MIAC alone, an analysis of the
amount of genital mycoplasma DNA in amniotic fluid samples was
performed in women with MIAC with or without HCA. A lower
amount of genital mycoplasmas was observed in women with
MIAC alone compared with those with both MIAC and HCA.
These findings are in line previous research in which a lower intra-
amniotic inflammatory response and a lower risk of subsequent
development of HCA were observed in PPROM pregnancies with
low bacterial load of genital mycoplasmas [28] Thus, in women
with MIAC alone, no significant differences were observed in
inflammatory response between genital mycoplasma detected by
PCR and other microorganisms isolated by culture ratifying the
fact that the lower inflammatory response observed in these
women was not microorganism-dependent [28].
Strengths and Limitations
One of the strengths of the study is the active management of
PPROM in our cohort, with most women delivering within 96 h
of membrane rupture (96/107). Since other studies with longer
latency periods have previously reported the lack of relationship
between HCA and latency period from membrane rupture to
delivery [29], we hypothesize that placenta pathology at birth
provided similar information as placenta pathology at amniocen-
tesis sampling in most of our women.
Our study also presents some limitations. The study was
performed in a single institution, which prevented the analysis of a
larger sample size. Short and long term neonatal outcomes were









N = 30 p1 p2 p3
IL-6 1576 (17–6659) 432 (28–3259) 198 (30–2672) 237 (40–1952) ,0.001 0.002 0.011
IL-8 456 (7–4000) 100 (4–4000) 24.5 (4–752) 34 (4–1262) ,0.001 0.434 0.097
IL-10 57 (4–2199) 16.5 (4–93) 12.5 (4–30) 14 (4–38) ,0.001 ,0.001 0.246
sIL-6r 523 (86–2970) 239 (69–1176) 154 (65–1622) 227 (38–1843) 0.003 0.050 0.626
Adinopectin 72356 (22370–357223) 39467 (13571–376591) 30006 (14550–79970) 39690 (12044–22995) 0.004 0.431 0.842
BDNF 227 (10–930) 119.5 (10–481) 112 (10–250) 121 (10–308) 0.002 0.033 0.835
CRP 3357 (162–17786) 2572 (402–24601) 1619.5 (427–8921) 1806 (223–9965) 0.030 0.526 0.466
GMC-SF 37 (4–161) 13 (4–48) 11 (4–79) 18 (4–53) 0.010 0.050 0.429
IGFBP-1 32876 (6229–189996) 19017.5 (8294–159405) 19217 (8406–50332) 24212 (4781–172740) 0.599 0.799 0.609
IGFBP-3 32915 (17202–44264) 30950 (6316–41363) 25094.5 (11870–41700) 33237 (9359–43279) 0.200 0.591 0.557
Leptin 1097 (126–7672) 959 (64–5324) 349.5 (42–1994) 825 (137–6345) 0.117 0.738 0.629
MCP-1 802 (50–2500) 163.5 (37–1131) 91.5 (38–912) 130 (54–719) ,0.001 ,0.001 0.532
MIF 8376 (1351–50000) 4521 (1768–50000) 4284.5 (1265–23173) 4909 (1313–21155) 0.045 0.686 0.680
MIP-1 412 (18–6355) 50.5 (9–666) 46 (4–377) 42 (4–165) ,0.001 ,0.001 0.289
MMP-9 5323 (571–87534) 2291 (608–16325) 1872 (461–12247) 1872 (529–7951) ,0.001 0.007 0.196
NT3 398 (217–2368) 365.5 (120–1259) 370 (180–890) 410 (232–697) 0.440 0.190 0.673
sTNF-R1 1199 (168–7517) 479.5 (135–3779) 254.5 (158–2838) 352 (138–3943) ,0.001 0.111 0.203
TREM-1 227 (43–2790) 171.5 (58–598) 155.5 (50–673) 161 (60–579) 0.031 0.055 0.813
p1: Continuous variables were compared using a nonparametric Jonckheere-Terpstra test and presented as medians (range).
p2: Spearman partial correlation was performed to adjust by gestational age at amniocentesis sampling.
p3: comparison between HCA alone, MIAC alone and non-infection detected subgroup.
doi:10.1371/journal.pone.0043677.t002
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N = 14 p1 p2
IL-6 2018.5 (17–6659) 568 (120–3259) 301 (62–2672) 284 (56–1952) ,0.001 0.054
IL-8 475.5 (7–4000) 110 (12–4000) 56 (8–752) 85.5 (4–1262) 0.001 0.199
IL-10 75 (4–2199) 21 (4–63) 13 (4–30) 19 (4–38) ,0.001 0.537
sIL-6r 694 (86–2970) 303 (69–1176) 231 (109–1622) 350 (69–1843) 0.201 0.692
Adinopectin 76449 (22370–357223) 66963 (18145–376591) 28285 (17489–79970) 68413.5 (24551–229905) 0.154 0.575
BDNF 268 (10–930) 191 (10–481) 132 (10–204) 131 (44–308) 0.027 0.382
CRP 3071 (162–17786) 2733 (402–20576) 3374 (691–8921) 1804.5 (223–8965) 0.307 0.486
GMC-SF 37.5 (4–161) 18 (4–33) 13 (4–79) 18.5 (4–32) 0.008 0.967
IGFBP-1 33689.5 (6229–172830) 27341 (15288–145255) 31254 (16833–50332) 42133 (7070–172740) 0.350 0.319
IGFBP-3 33651 (17202–44264) 33068 (7238–41363) 33742 (11870–41700) 33901 (17161–38206) 0.765 0.946
Leptin 1063 (126–6226) 1306 (64–5324) 355 (42–1342) 1124 (228–6345) 0.501 0.827
MCP-1 824 (50–2500) 171 (68–1131) 2972 (1759–12247) 2824.5 (626–7951) 0.002 0.913
MIF 8103 (1351–50000) 9025 (2832–50000) 7709 (4284–23173) 9041.5 (2266–21255) 0.883 0.712
MIP-1 495.5 (18–6355) 53 (11–176) 118 (53–912) 201.5 (62–719) ,0.001 0.672
MMP-9 7000 (571–87534) 3182 (1049–10076) 48 (12–377) 48 (17–165) 0.022 0.382
NT3 475 (235–2368) 481 (120–1259) 304 (180–644) 416 (277–692) 0.231 0.753
sTNF-R1 1219 (174–7517) 679 (309–3779) 328 (239–2838) 720.5 (215–3943) 0.066 0.539
TREM-1 228 (61–2790) 188 (58–598) 121 (67–351) 167.5 (60–457) 0.006 0.257
p1 Continuous variables were compared using a nonparametric Jonckheere-Terpstra test and presented as medians (range).
p2: comparison between HCA alone, MIAC alone and non-infection detected subgroup.
doi:10.1371/journal.pone.0043677.t003









N = 16 p1 p2
IL-6 1576 (378–3527) 401 (28–1323) 128 (30–1276) 174.5 (40–493) 0.003 0.168
IL-8 181 (171–1156) 58 (4–2411) 15 (4–77) 33 (4–233) 0.032 0.675
IL-10 19 (4–514) 14 (4–93) 12 (4–29) 10 (4–32) 0.154 0.331
sIL-6r 276 (129–846) 161 (90–808) 118 (65–463) 141.5 (38–562) 0.146 0.589
Adinopectin 68762 (25877–98918) 28011 (13571–189950) 31520 (14550–78013) 32832 (12044–57772) 0.257 0.818
BDNF 176 (74–360) 71 (10–154) 66 (10–250) 81.5 (10–271) 0.626 0.413
CRP 6555 (1888–17141) 2570 (685–246011) 1006 (427–3141) 1910.5 (618–9965) 0.183 0.675
GMC-SF 34 (4–99) 11 (4–48) 9 (4–27) 18 (4–5) 0.991 0.218
IGFBP-1 30859 (16670–189996) 1762 (8294–159405) 16140 (8406–49254) 21872.5 (4781–50354) 0.717 0.579
IGFBP-3 30889 (23371–35152) 20518 (6316–36763) 22700 (15358–29470) 2752.5 (9359–43279) 0.991 0.274
Leptin 1444 (281–7672) 355 (143–1513) 311 (138–1994) 23.5 (137–2905) 0.886 0.351
MCP-1 599 (303–2500) 161 (37–957) 60 (38–263) 109.5 (54–592) 0.020 0.552
MIF 11436 (3474–13335) 4053 (1768–15759) 03450 (1265–4615) 4173 (1313–15421) 0.333 0.746
MIP-1 102 (22–1460) 45 (9–666) 44 (4–124) 36 (4–102) 0.071 0.358
MMP-9 4772 (1510–6198) 1903 (608–16325) 1226 (461–2001) 1473 (529–5902) 0.097 0.797
NT3 262 (217–783) 350 (208–466) 541 (184–890) 372 (232–697) 0.235 0.433
sTNF-R1 425 (168–1714) 272 (135–1300) 231 (158–810) 258.5 (138–799) 0.202 0.607
TREM-1 119 (43–424) 133 (61–270) 158 (50–673) 179 (84–579) 0.403 0.351
p1 Continuous variables were compared using a nonparametric Jonckheere-Terpstra test and presented as medians (range).
p2: comparison between HCA alone, MIAC alone and non-infection detected subgroup.
doi:10.1371/journal.pone.0043677.t004
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not evaluated and therefore neonatal outcome regarding the
presence or absence of inflammatory status was not evaluated.
Also, we have not confirmed our microbial results with modern
non-cultivation technologies. Consequently, the size of the
subgroup with HCA alone and the non-infection detected
subgroup might have been overestimated, while the subgroups
with MIAC alone and with both MIAC and HCA might have
been underestimated. However, in most clinical settings, these
modern non-cultivation techniques are still not available, so
clinical decisions have to be based on standard methods. Besides, a
different non-infectious pathway to explain the activation of the
intra-amniotic inflammatory response (as the activation by
endogenous signals) has not been considered. Finally, other
standard tests of microbial infection such as Gram staining, white
blood count and glucose were not performed.
From a future perspective, assessment of inflammatory
biomarkers should be taken into consideration in the clinical
management of PPROM. Thus, the identification of a higher
inflammatory response in non-invasive samples, such as from the
cervix, seems to accurately reflect the status of the amniotic cavity
[30]. Therefore, the clinical applicability of a rapid test to
determine inflammatory response in amniotic fluid or non-invasive
samples of pregnant women complicated with PPROM would
probably improve the knowledge of intra-uterine status.
In summary, the identification of a high inflammatory status in
amniotic fluid in women with PPROM seems to translate a worse
infectious scenario in which MIAC and HCA are present.
Therefore, information exclusively from amniotic fluid culture
may be insufficient for clinical decision particularly in early
gestational ages. These results support further research to establish
the potential contribution of these inflammatory biomarkers in
amniotic fluid and non-invasive samples to the clinical manage-
ment of PPROM.
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